Cargando…

A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature

The clinical outcome of allogeneic hematopoietic stem cell transplantation (SCT) may be influenced by the metabolic status of the recipient following conditioning, which in turn may enable risk stratification with respect to the development of transplant-associated complications such as graft vs. ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Contaifer, Daniel, Roberts, Catherine H., Kumar, Naren Gajenthra, Natarajan, Ramesh, Fisher, Bernard J., Leslie, Kevin, Reed, Jason, Toor, Amir A., Wijesinghe, Dayanjan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721383/
https://www.ncbi.nlm.nih.gov/pubmed/31349646
http://dx.doi.org/10.3390/cancers11081051
_version_ 1783448331370889216
author Contaifer, Daniel
Roberts, Catherine H.
Kumar, Naren Gajenthra
Natarajan, Ramesh
Fisher, Bernard J.
Leslie, Kevin
Reed, Jason
Toor, Amir A.
Wijesinghe, Dayanjan S.
author_facet Contaifer, Daniel
Roberts, Catherine H.
Kumar, Naren Gajenthra
Natarajan, Ramesh
Fisher, Bernard J.
Leslie, Kevin
Reed, Jason
Toor, Amir A.
Wijesinghe, Dayanjan S.
author_sort Contaifer, Daniel
collection PubMed
description The clinical outcome of allogeneic hematopoietic stem cell transplantation (SCT) may be influenced by the metabolic status of the recipient following conditioning, which in turn may enable risk stratification with respect to the development of transplant-associated complications such as graft vs. host disease (GVHD). To better understand the impact of the metabolic profile of transplant recipients on post-transplant alloreactivity, we investigated the metabolic signature of 14 patients undergoing myeloablative conditioning followed by either human leukocyte antigen (HLA)-matched related or unrelated donor SCT, or autologous SCT. Blood samples were taken following conditioning and prior to transplant on day 0 and the plasma was comprehensively characterized with respect to its lipidome and metabolome via liquid chromatography/mass spectrometry (LCMS) and gas chromatography/mass spectrometry (GCMS). A pro-inflammatory metabolic profile was observed in patients who eventually developed GVHD. Five potential pre-transplant biomarkers, 2-aminobutyric acid, 1-monopalmitin, diacylglycerols (DG 38:5, DG 38:6), and fatty acid FA 20:1 demonstrated high sensitivity and specificity towards predicting post-transplant GVHD. The resulting predictive model demonstrated an estimated predictive accuracy of risk stratification of 100%, with area under the curve of the ROC of 0.995. The likelihood ratio of 1-monopalmitin (infinity), DG 38:5 (6.0), and DG 38:6 (6.0) also demonstrated that a patient with a positive test result for these biomarkers following conditioning and prior to transplant will be at risk of developing GVHD. Collectively, the data suggest the possibility that pre-transplant metabolic signature may be used for risk stratification of SCT recipients with respect to development of alloreactivity.
format Online
Article
Text
id pubmed-6721383
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67213832019-09-10 A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature Contaifer, Daniel Roberts, Catherine H. Kumar, Naren Gajenthra Natarajan, Ramesh Fisher, Bernard J. Leslie, Kevin Reed, Jason Toor, Amir A. Wijesinghe, Dayanjan S. Cancers (Basel) Article The clinical outcome of allogeneic hematopoietic stem cell transplantation (SCT) may be influenced by the metabolic status of the recipient following conditioning, which in turn may enable risk stratification with respect to the development of transplant-associated complications such as graft vs. host disease (GVHD). To better understand the impact of the metabolic profile of transplant recipients on post-transplant alloreactivity, we investigated the metabolic signature of 14 patients undergoing myeloablative conditioning followed by either human leukocyte antigen (HLA)-matched related or unrelated donor SCT, or autologous SCT. Blood samples were taken following conditioning and prior to transplant on day 0 and the plasma was comprehensively characterized with respect to its lipidome and metabolome via liquid chromatography/mass spectrometry (LCMS) and gas chromatography/mass spectrometry (GCMS). A pro-inflammatory metabolic profile was observed in patients who eventually developed GVHD. Five potential pre-transplant biomarkers, 2-aminobutyric acid, 1-monopalmitin, diacylglycerols (DG 38:5, DG 38:6), and fatty acid FA 20:1 demonstrated high sensitivity and specificity towards predicting post-transplant GVHD. The resulting predictive model demonstrated an estimated predictive accuracy of risk stratification of 100%, with area under the curve of the ROC of 0.995. The likelihood ratio of 1-monopalmitin (infinity), DG 38:5 (6.0), and DG 38:6 (6.0) also demonstrated that a patient with a positive test result for these biomarkers following conditioning and prior to transplant will be at risk of developing GVHD. Collectively, the data suggest the possibility that pre-transplant metabolic signature may be used for risk stratification of SCT recipients with respect to development of alloreactivity. MDPI 2019-07-25 /pmc/articles/PMC6721383/ /pubmed/31349646 http://dx.doi.org/10.3390/cancers11081051 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Contaifer, Daniel
Roberts, Catherine H.
Kumar, Naren Gajenthra
Natarajan, Ramesh
Fisher, Bernard J.
Leslie, Kevin
Reed, Jason
Toor, Amir A.
Wijesinghe, Dayanjan S.
A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature
title A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature
title_full A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature
title_fullStr A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature
title_full_unstemmed A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature
title_short A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature
title_sort preliminary investigation towards the risk stratification of allogeneic stem cell recipients with respect to the potential for development of gvhd via their pre-transplant plasma lipid and metabolic signature
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721383/
https://www.ncbi.nlm.nih.gov/pubmed/31349646
http://dx.doi.org/10.3390/cancers11081051
work_keys_str_mv AT contaiferdaniel apreliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT robertscatherineh apreliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT kumarnarengajenthra apreliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT natarajanramesh apreliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT fisherbernardj apreliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT lesliekevin apreliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT reedjason apreliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT tooramira apreliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT wijesinghedayanjans apreliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT contaiferdaniel preliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT robertscatherineh preliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT kumarnarengajenthra preliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT natarajanramesh preliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT fisherbernardj preliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT lesliekevin preliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT reedjason preliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT tooramira preliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature
AT wijesinghedayanjans preliminaryinvestigationtowardstheriskstratificationofallogeneicstemcellrecipientswithrespecttothepotentialfordevelopmentofgvhdviatheirpretransplantplasmalipidandmetabolicsignature